[ad_1]
Reuters
Photo from file
The CEO of the American pharmaceutical company “Pfizer”, Albert Burla, sold his shares of the company for $ 5.6 million, after the share price soared after a positive report on the effectiveness of the company’s vaccine against Corona.
The shares were sold on Monday, when the price per share reached $ 41.94, in the context of the issuance of a positive report on a vaccine against the Corona virus, which the company is developing in cooperation with the German company “Biontech “.
It’s worth noting that after the sale, Pfizer’s stock declined, closing Monday’s price at $ 38.5.
Pfizer defended the sale of 132,508 shares by its CEO of a near-peak value, stating in a statement that the deal was established in August “as part of Dr. Burla’s personal financial planning,” in line with a plan. previously drawn up allowing “major shareholders and insiders. Listed companies trade a specified number of shares at a predetermined time.
In addition to the CEO, his deputy, Sally Solman, also sold $ 1.8 million in stock he owns in the company.
In a related context, 90% of Americans stated that they are unlikely to receive the Pfizer vaccine, due to fear that it will be politicized or introduced without proper safety testing.
Source: RT
[ad_2]
